US$ 25.11
bpc-157 fda warning letter compounding FDA's Overreach on Compounded Peptides fda warning letter bpc-157 unapproved
Description
Purity / Appearance
Keep at least 1 inch between consecutive injection points in the same general area

Using bacteriostatic water for reconstitution helps prevent contamination because it contains 0.9% benzyl alcohol, which inhibits bacterial growth
This mechanism means AOD-9604 does not require appetite suppression to be effective, making it suitable for individuals who do not struggle with appetite control or who cannot tolerate the gastrointestinal side effects common with GLP-1 agonists
